Polymorphisms in the dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS) genes of Plasmodium falciparum and in vivo resistance to sulphadoxine/pyrimethamine in isolates from Tanzania

Tropical Medicine and International Health

Volumn 3, Issue 8, 1998, Pages 605-609

  Jelinek, T ^a,b   Ronn A M ^c   Lemnge, M M ^d   Curtis, J ^a   Mhina, J ^d   Duraisingh, M T ^a   Bygbjerg, I C ^c   Warhurst, D C ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF MUNICH   (Germany)

^c Rigshospitalet   (Denmark)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

Author keywords

Drug resistance; Malaria; Plasmodium falciparum; Tanzania

Indexed keywords

DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; DNA; FANSIDAR;

ARTICLE; CHILD; CLINICAL ARTICLE; DRUG RESISTANCE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; MALARIA; PLASMODIUM FALCIPARUM; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TANZANIA;

ANIMALS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; DIHYDROPTEROATE SYNTHASE; DNA PRIMERS; DRUG RESISTANCE, MICROBIAL; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PYRIMETHAMINE; SULFADOXINE; TANZANIA; TETRAHYDROFOLATE DEHYDROGENASE;

ANIMALIA; PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0031856277     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.1998.00280.x     Document Type: Article

References (17)

1. Anonymous. (1991) Basic Malaria Microscopy. World Health Organisation, Geneva.
2. Anonymous. (1996) Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission WHO/MAL/96.1077. World Health Organisation, Geneva.
3. Basco L, de Pecoulas P, Wilson C, Le Bras J & Mazabraud A (1995) Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Molecular Biochemistry and Parasitology 69, 135-138.
4. Brooks D, Wang P, Read M, Watkin W, Sims P & Hyde J (1994) Sequence variation in the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthetase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. European Journal of Biochemistry 224, 397-405.
5. Clyde D (1954) Observations on monthly pyrimethamine ('Daraprim') prophylaxis in an East African village. East African Medical Journal 3, 41-46.
6. Clyde D & Shute G (1957) Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals. Transactions of the Royal Society for Tropical Medicine and Hygiene 51, 505-513.
7. Curtis J, Duraisinghe MT, Trigg JK, Mbwana H, Warhurst DC & Curtis CF (1996) Direct evidence that asparagine at position 108 of the Plasmodium falciparum dihydrofolate reductase is involved in resistance to antifolate drugs in Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene 90, 678-680.
8. Foote S, Galatis D & Cowman A (1990) Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proceedings of the National Academy of Sciences of the USA 87, 3014-3017.
9. Jelinek T, Ronn A, Curtis J, Duraisingh M, Lemnge M, Mhina J, Bygbjerg I & Warhurst D (1997) High prevalence of mutations in the dihydrofolate reductase gene of Plasmodium falciparum in isolates from Tanzania without association to clinical resistance to sulfadoxine/pyrimethamine. Tropical Medicine and International Health 2, 1075-1079.
10. Pääbo S (1990) Amplifying ancient DNA. In PCR Protocols, (eds M. Innis, D. Gelfand, J. Sninsky & T. White), Academic Press, London, pp. 159-166.
11. Peterson D, Milhous W & Wellems T (1990) Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proceedings of the National Academy of Sciences of the USA 87, 3018-3022.
12. Plowe CV, Djimde A, Bouare M, Doumbo O & Wellems TE (1995) Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. American Journal of Tropical Medicine and Hygiene 52, 565-568.
13. Reeder J, Rieckmann K, Genton B, Lorry K, Wines B & Cowman A (1996) Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea. American Journal of Tropical Medicine and Hygiene 55, 209-213.
14. Ronn A, Msangeni H, Mhina J, Wernsdorfer W & Bybjerg I (1996) High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Transactions of the Royal Society of Tropical Medicine and Hygiene 50, 179-181.
15. Shapira A, Bygbjerg I, Jepsen S, Flachs H & Bentzon M (1986) The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results. American Journal of Tropical Medicine and Hygiene 35, 239-245.
16. Timmermanns P, Hess U & Jones M (1982) Pyrimethamine/ sulfadoxine resistant falciparum malaria in East Africa. Lancet i, 1181.
17. Triglia T & Cowman AF (1994) Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proceedings of the National Academy of Sciences of the USA 91, 7149-7153.